Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bergman

Showing results (571-580 of 904) with videos related to

Pageof 91
Sort By:
Biochemical Pharmacology|February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinaseA M Bergman, H M Pinedo, A P Jongsma, et al.
Clinical and Translational Gastroenterology|October 27, 2020
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal AnalysisNicola F Frei, Kadère Konte, Emily A Bossart, et al.
Endocrine-Related Cancer|December 6, 2019
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional programSuzan Stelloo, Simon Linder, Ekaterina Nevedomskaya, et al.
Lasers in Medical Science|December 6, 2015
Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membraneJasmin A Holz, David F Boerwinkel, Sybren L Meijer, et al.
Cancer Research|November 17, 2005
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrationsMark A van de Wiel, Jose L Costa, Kees Smid, et al.
Bioinformatics (Oxford, England)|January 7, 2006
ORegAnno: an open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variationS B Montgomery, O L Griffith, M C Sleumer, et al.
Genes, Chromosomes & Cancer|February 12, 2008
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimensAgnieszka M Rygiel, Francesca Milano, Febo J Ten Kate, et al.
Endoscopy|January 24, 2025
Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic reviewCharlotte N Frederiks, Laura S Boer, Bas Gloudemans, et al.
Endoscopy|March 4, 2021
Novel cryoballoon 180° ablation system for treatment of Barrett's esophagus-related neoplasia: a first-in-human studyAnouk Overwater, Sanne N van Munster, Wouter B Nagengast, et al.
Biochimica Et Biophysica Acta|March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell linesC J van Moorsel, A M Bergman, G Veerman, et al.
Pageof 91

Showing results (571-580 of 904) with videos related to

Sort By:
Pageof 91
Biochemical Pharmacology|February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinaseA M Bergman, H M Pinedo, A P Jongsma, et al.
Clinical and Translational Gastroenterology|October 27, 2020
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal AnalysisNicola F Frei, Kadère Konte, Emily A Bossart, et al.
Endocrine-Related Cancer|December 6, 2019
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional programSuzan Stelloo, Simon Linder, Ekaterina Nevedomskaya, et al.
Lasers in Medical Science|December 6, 2015
Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membraneJasmin A Holz, David F Boerwinkel, Sybren L Meijer, et al.
Cancer Research|November 17, 2005
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrationsMark A van de Wiel, Jose L Costa, Kees Smid, et al.
Bioinformatics (Oxford, England)|January 7, 2006
ORegAnno: an open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variationS B Montgomery, O L Griffith, M C Sleumer, et al.
Genes, Chromosomes & Cancer|February 12, 2008
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimensAgnieszka M Rygiel, Francesca Milano, Febo J Ten Kate, et al.
Endoscopy|January 24, 2025
Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic reviewCharlotte N Frederiks, Laura S Boer, Bas Gloudemans, et al.
Endoscopy|March 4, 2021
Novel cryoballoon 180° ablation system for treatment of Barrett's esophagus-related neoplasia: a first-in-human studyAnouk Overwater, Sanne N van Munster, Wouter B Nagengast, et al.
Biochimica Et Biophysica Acta|March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell linesC J van Moorsel, A M Bergman, G Veerman, et al.
Pageof 91